NEW YORK (Reuters Health) – In patients with mild renal insufficiency, a single IV bolus of sodium bicarbonate can help prevent contrast-induced nephropathy (CIN) during percutaneous coronary intervention…
NEW YORK (Reuters Health) – In non-diabetic patients with hypertensive kidney disease, the risk of hyperkalemia with angiotensin converting enzyme (ACE) inhibitors is “small,” according to research reported…
NEW YORK (Reuters Health) – High-dose N-acetylcysteine decreases the incidence of contrast-induced nephropathy, results of a meta-analysis indicate. “N-acetylcysteine has the advantages of being relatively innocuous, inexpensive, and…
NEW YORK (Reuters Health) – Giving low-dose dopamine to brain-dead donors can improve graft function after kidney transplantation, according to trial findings reported in the Journal of the…
NEW YORK (Reuters Health) – As a treatment for renal tumors, robot-assisted partial nephrectomy (RAPN) offers comparable oncologic control as traditional laparoscopic nephrectomy, but with less blood loss,…
Jaime Landman MD, Director of Minimally Invasive Urology at Columbia University Medical Center, describes the next step after minimally invasive laparascopic partial nephrectomy in the treatment of renal…
NEW YORK (Reuters Health) – A meta-analysis of trial data suggests that erythropoietin can be safely used to treat anemia in patients with chronic heart failure and may…
NEW YORK (Reuters Health) – Even when patients with type 1 diabetes have excellent hemoglobin A1C levels, continuous glucose monitoring will be beneficial, according to a report in…
NEW YORK (Reuters Health) – In patients with metastatic renal cell carcinoma, first-line treatment with interferon (IFN)-alpha plus sunitinib or bevacizumab has “clinically relevant and statistically significant” survival…
NEW YORK (Reuters Health) – The results of a 30-year study indicate that intensive glucose control can substantially reduce the rates of retinopathy, nephropathy, and cardiovascular disease in…